• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Valo Health

Brain and money connected by a thread on a white background
Biotech

Merck KGaA becomes latest partner for Flagship’s Valo Health

Merck and Valo will use the latter’s discovery platform to quickly craft preclinical candidates for newly identified Parkinson's disease targets.
Darren Incorvaia Nov 20, 2025 6:30am
Flagship Pioneering office

Pfizer, Flagship turn to autoimmune for latest angle of collab

Apr 1, 2025 9:38am
AI drug discovery pill machine learning drug targets data

Charles River and Valo pact nets preclinical lupus asset

Mar 26, 2025 6:30am
concept of computer chip and dollar sign

Novo bets $190M near-term on AI pact in obesity, diabetes

Jan 8, 2025 8:00am
eye eyeball eye art

Valo abandons ROCK inhibitor after diabetic retinopathy fail

Jan 2, 2025 9:43am
photo of a paraglider in the foreground with the alps in the background

Flagship-backed biotechs name new leaders—Chutes & Ladders

Nov 15, 2024 8:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings